298
Views
20
CrossRef citations to date
0
Altmetric
Article

Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway

, , , , , & show all
Pages 1217-1227 | Received 30 Jan 2020, Accepted 29 May 2020, Published online: 22 Jul 2020
 

Abstract

To better understand the link between obesity and prostate cancer (PC) aggressiveness, we investigate the role of leptin, an obesity associated adipokine, and its receptor (Ob-R) in PC cells migration. The migration assay (Wound-healing) was used to study the leptin impact on DU-145 and PC3 cells lines. STAT3 activation was performed by Western Blot. E-cadherin expression was studied using fluorescence microscopy and Ob-R expression in PC and benign prostatic Hyperplasia (BPH) biopsies was assessed by RT-PCR. In this study we demonstrate that high dose of leptin promotes PC cells migration and EMT transition via the stimulation of STAT3 pathway. In addition, we report that although Ob-R mRNA is expressed by ADK and BPH resections biopsies, significant higher levels were observed for ADK patients. Finally, we found a positive association between Ob-R mRNA expression and worse PC prognosis. A better understanding of the molecular processes of leptin signaling is crucial for identifying appropriate approaches for treatment of obesity-related PC patients.

Disclosure Statement

No conflict of interest

Authors’ Contributions

AG designed research and revised the manuscript. AG, AP and AK performed all research experiments and drafted the manuscript. MC, AD and HK assisted with the research experiments and revised the manuscript. AP, AK helped to designed research and revised the manuscript. All authors approved the final manuscript.

Additional information

Funding

This work was financially supported by the Tunisian Ministry of Higher Education and Scientific Research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.